return to news
  1. Mastek block deal: Firm's shares settle 1% lower as 7.6% equity changes hands

Market News

Mastek block deal: Firm's shares settle 1% lower as 7.6% equity changes hands

Upstox

2 min read | Updated on September 04, 2024, 15:52 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Shares of the company have rallied nearly 23% in the past 12 months and around 787% over the past five years.

Stock list

Last week, Mastek announced a strategic partnership with Onyx Health, an innovator in healthcare interoperability solutions.

Last week, Mastek announced a strategic partnership with Onyx Health, an innovator in healthcare interoperability solutions.

Shares of midcap IT services company Mastek ended over 1% lower at ₹2,871 apiece on the BSE on Wednesday, September 4, after news reports suggested that 23.5 lakh shares, or 7.6% equity worth ₹647.5 crore, changed hands at ₹2,750 per share. 

Last week, Mastek announced a strategic partnership with Onyx Health, an innovator in healthcare interoperability solutions. This collaboration aims to expedite the adoption of FHIR (Fast Healthcare Interoperability Resources) standards, driving enhanced data interoperability and ultimately better health outcomes for patients, the company said.

Mastek Q1 FY25 Results

The company's consolidated net profit tumbled 24.27% to ₹71.50 crore in Q1 FY25 as against ₹94.41 crore reported in Q4 FY24. However, revenue from operations grew by 4.25% quarter on quarter (QoQ) to ₹812.89 crore in the quarter ended 30 June 2024.

On a year-on-year (YoY) basis, Mastek's net profit declined 2.76% while revenue rose 12.08% in Q1 FY25, as per news reports.

Operating EBITDA was at ₹123.9 crore in the June quarter, registering a decline of 0.9% QoQ and 2.4% YoY. Operating EBITDA margin reduced to 15.2% in Q1 FY25 as compared to 16% in Q4 FY24 and 17.5% in Q1 FY24.

In terms of dollars, the firm's revenue was $97.3 million in Q1 FY25, up 3.8% QoQ and 10.4% YoY. In constant currency terms, revenue was up by 4.1% QoQ and 9.9% YoY.

Twelve-month order backlog was at ₹2,168.8 crore ($260.1 million) as of June 30, 2024, as compared to ₹1,763.9 crore ($215.0 million) in Q1FY24, reflecting growth of 23% in rupee terms and 21% in constant currency terms on a YoY basis and ₹2,168.4 crore ($260.0 million) in Q4 FY24.

Mastek share price performance

Shares of the company have rallied nearly 23% in the past 12 months and around 787% over the past five years.

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Next Story